Acute Amino Acid d-Serine Administration, Similar to Ketamine, Produces Antidepressant-like Effects through Identical Mechanisms
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
d-Serine is an amino acid and can work as an agonist at the glycine sites of N-methyl-d-aspartate receptor (NMDAR). Interestingly, both types of glutamatergic modulators, NMDAR enhancers and blockers, can improve depression through common targets, namely alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionaic acid receptors (AMPARs) and mammalian target of rapamycin (mTOR). To elucidate the cellular signaling pathway underlying this counterintuitive observation, we activated NMDARs in rats by using d-serine. Saline, ketamine (NMDAR antagonist), and desipramine (tricyclic antidepressant) were used as controls. The antidepressant-like effects of all agents were evaluated using the forced swim test. The activation of the AMPAR-mTOR signaling pathway, release of brain-derived neurotrophic factor (BDNF), and alteration of AMPAR and NMDAR trafficking in the hippocampus of rats were examined. A single high dose of d-serine exerted an antidepressant-like effect that was mediated by rapid AMPAR-induced mTOR signaling pathway and increased BDNF proteins, identical to that of ketamine. Furthermore, in addition to the increased protein kinase A phosphorylation of the AMPAR subunit GluR1 (an indicator of AMPAR insertion in neurons), treatment with individual optimal doses of d-serine and ketamine also increased adaptin β2-NMDAR association (an indicator of the intracellular endocytic machinery and subsequent internalization of NMDARs). Desipramine did not influence these processes. Our study is the first to demonstrate an association between d-serine and ketamine; following adaptative regulation of AMPAR and NMDAR may lead to common changes of them. These findings provide novel targets for safer antidepressant agents with mechanisms similar to those of ketamine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Simple Practice Guide for Dose Conversion between Animals and Human
Nair, A., & Jacob, S. (2016) · Journal of Basic and Clinical Pharmacy · doi:10.4103/0976-0105.177703 · Cited by 6,174
Behavioural despair in rats: A new model sensitive to antidepressant treatments
Porsolt, R. D., Anton, G., Blavet, N., & Jalfre, M. (1978) · European Journal of Pharmacology · doi:10.1016/0014-2999(78)90118-8 · Cited by 3,138
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
Maeng, S., Zarate, C. A., Du, J., Schloesser, R. J., McCammon, J., Chen, G., & Manji, H. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.028 · Cited by 1,103
PKA phosphorylation of AMPA receptor subunits controls synaptic trafficking underlying plasticity
Esteban, J. A., Shi, S.-H., Wilson, C., Nuriya, M., Huganir, R. L., & Malinow, R. (2003) · Nature Neuroscience · doi:10.1038/nn997 · Cited by 894
Regulatory mechanisms of AMPA receptors in synaptic plasticity
Derkach, V. A., Oh, M. C., Guire, E. S., & Soderling, T. R. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2055 · Cited by 708
Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase
Banke, T. G., Bowie, D., Lee, H.-K., Huganir, R. L., Schousboe, A., & Traynelis, S. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00089.2000 · Cited by 652
Targeting glutamate signalling in depression: progress and prospects
Murrough, J. W., Abdallah, C. G., & Mathew, S. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.16 · Cited by 482
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
Browne, C. A., & Lucki, I. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00161 · Cited by 285
Burgdorf, J., Zhang, X.-L., Nicholson, K. L., Balster, R. L., David Leander, J., Stanton, P. K., Gross, A. L., Kroes, R. A., & Moskal, J. R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.246 · Cited by 284
High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia
Heresco-Levy, U., Ermilov, M., Lichtenberg, P., Bar, G., & Javitt, D. C. (2004) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00707-8 · Cited by 222
Smith, K. E., Gibson, E. S., & Dell’Acqua, M. L. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3092-05.2006 · Cited by 141
Moaddel, R., Luckenbaugh, D. A., Xie, Y., Villaseñor, A., Brutsche, N. E., Machado-Vieira, R., Ramamoorthy, A., Lorenzo, M. P., Garcia, A., Bernier, M., et al. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3669-0 · Cited by 86
Hashimoto, K. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3735-7 · Cited by 16
Research works printed but not linked: 56
- 10.1017/neu.2015.59 · DOI
- 10.1016/j.pnpbp.2015.02.015 · DOI
- Sawa A., 2003, Mol. Med., 9, 3, 10.1007/BF03402101 · DOI · Paper page
- 10.1016/j.jpsychires.2013.06.013 · DOI
- 10.1093/schbul/sbs100 · DOI
- 10.1001/archpsyc.1994.03950030035004 · DOI · Paper page
- 10.1016/S0006-3223(99)00230-9 · DOI · Paper page
- 10.1016/j.biopsych.2016.12.020 · DOI · Paper page
- 10.1017/S1092852900010403 · DOI · Paper page
- 10.1126/science.1190287 · DOI · Paper page
- Javitt D. C., 1987, Hillside J. Clin. Psychiatry, 9, 12
- 10.1176/ajp.148.10.1301 · DOI · Paper page
- 10.1097/00001756-199504190-00011 · DOI · Paper page
- 10.1001/archpsyc.62.11.1196 · DOI · Paper page
- 10.1016/j.biopsych.2006.04.005 · DOI · Paper page
- 10.1016/j.biopsych.2007.04.038 · DOI · Paper page
- 10.1038/sj.npp.1300772 · DOI · Paper page
- 10.1017/S1461145711001386 · DOI · Paper page
- 10.1016/j.pnpbp.2016.06.002 · DOI
- 10.1016/j.biopsych.2013.02.020 · DOI
- 10.1016/S0014-2999(96)00675-9 · DOI
- 10.1016/j.jpsychires.2014.12.007 · DOI
- 10.1001/jamapsychiatry.2013.2159 · DOI · Paper page
- 10.1113/jphysiol.2009.168757 · DOI
- 10.1016/0896-6273(92)90207-T · DOI · Paper page
- 10.3389/fnbeh.2015.00162 · DOI
- 10.1093/ijnp/pyv102 · DOI · Paper page
- 10.1517/13543784.2014.852536 · DOI · Paper page
- 10.1155/2014/859735 · DOI
- 10.1126/science.2841759 · DOI · Paper page
- Berger A. J., 1998, J. Neurophysiol., 80, 3336, 10.1152/jn.1998.80.6.3336 · DOI · Paper page
- 10.1073/pnas.97.9.4926 · DOI · Paper page
- 10.1179/174313209X459174 · DOI
- 10.1038/266730a0 · DOI · Paper page
- 10.1016/0165-0270(85)90031-7 · DOI · Paper page
- 10.1016/j.brainresbull.2008.03.005 · DOI
- 10.1016/0091-3057(95)00138-M · DOI · Paper page
- 10.1016/0091-3057(95)02126-4 · DOI · Paper page
- 10.1016/j.expneurol.2003.09.024 · DOI
- 10.1038/nature01497 · DOI · Paper page
- 10.1016/S0166-2236(02)02272-5 · DOI · Paper page
- 10.1038/35044540 · DOI · Paper page
- 10.1016/j.biopsych.2013.02.020 · DOI
- 10.1016/j.jad.2013.11.014 · DOI · Paper page
- 10.1016/j.bbr.2011.02.003 · DOI
- 10.1038/88404 · DOI · Paper page
- 10.2174/157015911795017155 · DOI · Paper page
- 10.1016/j.tox.2015.04.017 · doi:10.1016/j.tox.2015.04.017
- 10.1016/j.reprotox.2004.10.003 · DOI
- 10.1016/j.biopsych.2013.04.025 · DOI · Paper page
- 10.1016/j.biopsych.2006.02.013 · DOI · Paper page
- 10.1016/j.schres.2010.05.012 · DOI · Paper page
- 10.18632/oncotarget.7691 · DOI
- 10.1038/mp.2015.61 · DOI
- 10.1038/mp.2012.10 · DOI
- 10.1016/j.biopsych.2011.10.034 · DOI
Cited by
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Zanos, P., Moaddel, R., Morris, P. J., Riggs, L. M., Highland, J. N., Georgiou, P., Pereira, E. F. R., Albuquerque, E. X., Thomas, C. J., Zarate, C. A., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015198 · Cited by 1,260
Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
Wei, Y., Chang, L., & Hashimoto, K. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01121-1 · Cited by 248
Matveychuk, D., Thomas, R. K., Swainson, J., Khullar, A., MacKay, M.-A., Baker, G. B., & Dursun, S. M. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320916657 · Cited by 209
Linking What We Eat to Our Mood: A Review of Diet, Dietary Antioxidants, and Depression
Huang, Q., Liu, H., Suzuki, K., Ma, S., & Liu, C. (2019) · Antioxidants · doi:10.3390/antiox8090376 · Cited by 144
“These protective effects were partially achieved through the inhibition of neuroinflammatory disturbance and the regulation of TRP–KYN metabolism both in the brain and in the periphery [150].”
Background
Metadata
- Authors
- Wei, I.-H., Chen, K.-T., Tsai, M.-H., Wu, C.-H., Lane, H.-Y., & Huang, C.-C.
- Venue
- Journal of Agricultural and Food Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-12-04
- Volume
- 65
- Issue
- 49
- Pages
- 10792-10803
- ISSN
- 0021-8561 (ISSN-L)
- 1520-5118
- OpenAlex
- W2769323508
- Cited by
- 42
- References
- 15
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Funders
- China Medical University Hospital (DMR-105-075, DMR-106-096)
- Ministry of Science and Technology, Taiwan (MOST 105-2314-B-039-027, MOST 105-2320-B-039-013-MY3, MOST 106-2314-B-039-029-MY3)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.